|
This is an index of reports of adverse events (side effects, adverse reactions, etc.) related to Estrace (Estradiol Vaginal). Click on the relevant link below to view a selection of reports according to the event's seriousness level and/or the nature of the side effect / adverse reaction. Or scroll down to view a sample of recent reports further on this page.
Our database includes reports from Jan 2007 to Dec 2007. The information is not vetted and should not be cosidered as verified clinical evidence.
All cases (70)
Cases resulting in a serious event (70)
Cases resulting in death (7)
Cases resulting in hospitalization (12)
Cases resulting in disability (1)
Cases resulting in other serious reactions (70)
Below is a sample of reports where side effects / adverse reactions may be related to Estrace (Estradiol Vaginal). For a complete list and/or a specific selection of reports, please use the links in the index above.
Adverse event in female receiving Estrace (Estradiol Vaginal)
Reported by a consumer/non-health professional from United States on 2007-10-31
Patient: female, weighing 79.5 kg (174.8 pounds)
Adverse reactions / side effects: Ovarian Cancer Metastatic
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Estrace
Estradiol
Dosage: unknown
Administration route: Oral
Indication: Menopausal Symptoms Prophylaxis
Start date: 1989-01-01
Estrogens Esterified / Methyltestosterone
Premarin
Dosage: unspecified
Administration route: Oral
Start date: 1992-01-01
End date: 2004-01-01
Other drugs received by patient: Xanax
Adverse event in female receiving Estrace (Estradiol Vaginal)
Reported by a consumer/non-health professional from United States on 2007-10-31
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Cycrin
Estrace
Prempro
Provera
Adverse event in 63 year old female receiving Estrace (Estradiol Vaginal)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 63 year old female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Estrace
Dosage: oral
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1989-05-24
End date: 1998-03-11
Premarin
Dosage: oral
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1986-03-01
End date: 1989-05-24
Provera
Dosage: oral
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1986-03-01
End date: 1989-05-24
Adverse event in female receiving Estrace (Estradiol Vaginal)
Reported by a consumer/non-health professional from United States on 2007-10-30
Patient: female, weighing 59.0 kg (129.8 pounds)
Adverse reactions / side effects: Breast Cancer Metastatic
Adverse event resulted in: hospitalization
Suspect drug(s):
Estrace
Premarin
Dosage: unknown
Indication: Oestrogen Replacement Therapy
Start date: 1994-01-01
End date: 1996-01-01
Prempro
Dosage: unknown
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1996-01-01
End date: 2002-01-01
Provera
Dosage: unknown
Indication: Hormone Replacement Therapy
Start date: 1996-01-01
End date: 2002-01-01
Adverse event in 48 year old female receiving Estrace (Estradiol Vaginal)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 48 year old female, weighing 108.0 kg (237.7 pounds)
Adverse reactions / side effects: Weight Decreased, Breast Cancer, Depression
Suspect drug(s):
Estrace
Dosage: oral
Administration route: Oral
Indication: Anxiety
Start date: 1995-06-01
Estratest
Indication: Anxiety
Start date: 1983-05-21
End date: 1984-03-01
Premarin
Dosage: 1.25mg daily, oral
Administration route: Oral
Indication: Anxiety
Start date: 1984-03-01
Adverse event in 48 year old female receiving Estrace (Estradiol Vaginal)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 48 year old female, weighing 108.0 kg (237.7 pounds)
Adverse reactions / side effects: Weight Decreased, Breast Cancer, Depression
Suspect drug(s):
Estrace
Dosage: oral
Administration route: Oral
Indication: Anxiety
Start date: 1995-06-01
Estratest
Indication: Anxiety
Start date: 1983-05-21
End date: 1984-03-01
Premarin
Dosage: 1.25mg daily, oral
Administration route: Oral
Indication: Anxiety
Start date: 1984-03-01
Adverse event in female receiving Estrace (Estradiol Vaginal)
Reported by a consumer/non-health professional from United States on 2007-10-30
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Adverse event resulted in: hospitalization
Suspect drug(s):
Estrace
Estradiol
Medroxyprogesterone Acetate
Premarin
Prempro
Provera
Adverse event in 64 year old female receiving Estrace (Estradiol Vaginal)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 64 year old female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Estrace
Estratab
Premarin
Provera
Adverse event in 63 year old female receiving Estrace (Estradiol Vaginal)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 63 year old female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Estrace
Dosage: oral
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1989-05-22
End date: 1998-03-11
Premarin
Dosage: oral
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1989-03-01
End date: 1989-05-24
Provera
Dosage: oral
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1986-03-01
End date: 1989-05-24
Adverse event in female receiving Estrace (Estradiol Vaginal)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Cycrin
Estrace
Estradiol
Premarin
Provera
Adverse event in female receiving Estrace (Estradiol Vaginal)
Reported by a consumer/non-health professional from United States on 2007-10-29
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Conjugated Estrogens
Cycrin
Dosage: unknown
Indication: Hormone Replacement Therapy
Estrace
Estratest
Dosage: unknown
Indication: Hormone Replacement Therapy
Medroxyprogesterone Acetate
Dosage: unknown
Indication: Hormone Replacement Therapy
Premarin
Dosage: unknown
Indication: Oestrogen Replacement Therapy
Premphase 14 / 14
Dosage: unknown
Indication: Hormone Replacement Therapy
Prempro
Dosage: unknown
Indication: Hormone Replacement Therapy
Provera
Dosage: unknown
Indication: Hormone Replacement Therapy
Unspecified Estrogen Replacement Therapy
Dosage: unknown
Indication: Oestrogen Replacement Therapy
Adverse event in 66 year old female receiving Estrace (Estradiol Vaginal)
Reported by a consumer/non-health professional from United States on 2007-10-12
Patient: 66 year old female
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Estrace
Estropipate
Medroxyprogesterone Acetate
Prempro
Indication: Menopausal Symptoms
Provera
Adverse event in female receiving Estrace (Estradiol Vaginal)
Reported by a consumer/non-health professional from United States on 2007-10-12
Patient: female, weighing 65.8 kg (144.8 pounds)
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Estrace
Dosage: unknown
Administration route: Oral
Indication: Menopausal Symptoms
Start date: 1980-01-01
End date: 2003-08-01
Premarin
Dosage: unknown
Administration route: Oral
Indication: Menopausal Symptoms
Start date: 1974-01-01
End date: 1980-08-01
Provera
Dosage: unkonwn
Administration route: Oral
Indication: Menopausal Symptoms
Start date: 1974-01-01
End date: 2003-08-01
Adverse event in female receiving Estrace (Estradiol Vaginal)
Reported by a lawyer from United States on 2007-10-08
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Estrace
Estratest
Estrogens
Prempro
Provera
Adverse event in 74 year old female receiving Estrace (Estradiol Vaginal)
Reported by a consumer/non-health professional from United States on 2007-10-08
Patient: 74 year old female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Cycrin
Indication: Menopausal Symptoms
Estrace
Indication: Menopausal Symptoms
Estraderm
Indication: Menopausal Symptoms
Estradiol
Indication: Menopausal Symptoms
Estratab
Indication: Menopausal Symptoms
Estratest
Indication: Menopausal Symptoms
Ogen
Indication: Menopausal Symptoms
Premarin
Indication: Menopausal Symptoms
Prempro
Indication: Menopausal Symptoms
Provera
Indication: Menopausal Symptoms
Adverse event in 61 year old female receiving Estrace (Estradiol Vaginal)
Reported by a pharmacist from United States on 2007-10-05
Patient: 61 year old female
Adverse reactions / side effects: Mass, Nipple Pain, Vaginal Disorder
Adverse event resulted in: death
Suspect drug(s):
Estrace (Estradiol Vaginal)
Adverse event in female receiving Estrace (Estradiol Vaginal)
Reported by a lawyer from United States on 2007-07-31
Patient: female
Adverse reactions / side effects: Breast Cancer Female
Adverse event resulted in: death
Suspect drug(s):
Estrace
Indication: Menopausal Symptoms
Start date: 1995-01-01
End date: 2000-01-01
Estratest
Indication: Menopausal Symptoms
Start date: 1995-01-01
End date: 2000-01-01
Premarin
Indication: Menopausal Symptoms
Start date: 1995-01-01
End date: 2000-01-01
Provera
Administration route: Oral
Indication: Menopausal Symptoms
Start date: 1995-01-01
End date: 2000-01-01
Adverse event in female receiving Estrace (Estradiol Vaginal)
Reported by a consumer/non-health professional from United States on 2007-07-27
Patient: female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Estrace
Indication: Menopausal Symptoms
Estradiol Valerate
Indication: Ovarian Failure Postoperative
Estratest H.s.
Indication: Menopausal Symptoms
Premarin
Indication: Menopausal Symptoms
Provera
Indication: Menopausal Symptoms
Adverse event in female receiving Estrace (Estradiol Vaginal)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-07-27
Patient: female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Estrace
Indication: Hormone Therapy
Estrogen
Indication: Hormone Therapy
Medroxyprogesterone Acetate
Indication: Hormone Therapy
Premarin
Indication: Hormone Therapy
Prempro
Indication: Hormone Therapy
Provera
Indication: Hormone Therapy
Adverse event in 48 year old female receiving Estrace (Estradiol Vaginal)
Reported by a consumer/non-health professional from United States on 2007-07-26
Patient: 48 year old female
Adverse reactions / side effects: Breast Cancer Stage II
Suspect drug(s):
Estrace
Indication: Menopausal Symptoms
Start date: 1993-01-01
End date: 1998-01-01
Estraderm
Indication: Menopausal Symptoms
Start date: 1993-01-01
End date: 1998-01-01
Estratest
Administration route: Oral
Indication: Menopausal Symptoms
Start date: 1993-01-01
End date: 1998-01-01
Premarin
Administration route: Oral
Indication: Menopausal Symptoms
Start date: 1993-01-01
End date: 1998-01-01
Provera
Administration route: Oral
Indication: Menopausal Symptoms
Start date: 1993-01-01
End date: 1998-01-01
Other drugs received by patient: Zoloft
Adverse event in 56 year old female receiving Estrace (Estradiol Vaginal)
Reported by a individual with unspecified qualification from United States on 2007-07-18
Patient: 56 year old female
Adverse reactions / side effects: Biopsy Breast Abnormal, Urinary Incontinence, Biopsy Endometrium Abnormal, Cystocele, Smear Cervix Abnormal, Road Traffic Accident, Neck Pain, Breast Microcalcification, Intervertebral Disc Degeneration, Back Pain, Breast Cancer, Pelvic Fracture, Radiculitis Lumbosacral, Accident, Rectocele, Uterine Prolapse, Bladder Disorder
Suspect drug(s):
Estrace
Dosage: 1 mg, unk
Indication: Menopause
Start date: 1998-04-01
End date: 1998-12-01
Premarin
Dosage: 0.625 mg, unk
Administration route: Oral
Indication: Menopause
Start date: 1994-07-01
End date: 1998-03-01
Prometrium
Dosage: 100 mg, unk
Indication: Menopause
Start date: 1999-11-01
End date: 2001-04-01
Provera
Dosage: 10 mg, unk
Administration route: Oral
Indication: Menopause
Start date: 1994-07-01
End date: 1997-01-01
Vivelle
Dosage: 0.05 mg/day, unk
Indication: Menopause
Start date: 2000-06-01
End date: 2002-02-01
Vivelle-DOT
Adverse event in female receiving Estrace (Estradiol Vaginal)
Reported by a consumer/non-health professional from United States on 2007-07-11
Patient: female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Activella
Dosage: oral
Administration route: Oral
Indication: Hormone Replacement Therapy
Estrace
Dosage: oral
Administration route: Oral
Indication: Hormone Replacement Therapy
Provera
Dosage: oral
Administration route: Oral
Indication: Hormone Replacement Therapy
Adverse event in 57 year old female receiving Estrace (Estradiol Vaginal)
Reported by a individual with unspecified qualification from United States on 2007-07-05
Patient: 57 year old female, weighing 68.0 kg (149.7 pounds)
Adverse reactions / side effects: Tooth Extraction, Neck Injury, Skin Burning Sensation, Breast Cancer in Situ, Malignant Breast Lump Removal, Rash, Biopsy, Biopsy Site Unspecified Abnormal, Erythema, Skin Reaction, Hot Flush, Road Traffic Accident, Depression, Bone Density Decreased, Ligament Sprain
Suspect drug(s):
Combipatch
Indication: Menopause
Start date: 2002-11-14
End date: 2002-12-31
Estrace
Estratest
Oral Contraceptive NOS
Dosage: unk, unk
Administration route: Oral
Start date: 1965-01-01
End date: 1972-01-01
Prempro
Indication: Menopause
Start date: 1996-01-01
End date: 1999-01-01
Provera
Indication: Menopause
Start date: 1999-06-01
End date: 2005-03-01
Other drugs received by patient: Tamoxifen Citrate; Arimidex
Adverse event in 62 year old female receiving Estrace (Estradiol Vaginal)
Reported by a individual with unspecified qualification from United States on 2007-07-02
Patient: 62 year old female, weighing 99.8 kg (219.5 pounds)
Adverse reactions / side effects: Polyp Colorectal, Mammogram Abnormal, Fibrocystic Breast Disease, Intervertebral Disc Disorder, Postmenopausal Haemorrhage, Breast Microcalcification, Blood Cholesterol Increased, Benign Breast Neoplasm, Breast Hyperplasia, Breast Cancer, Tonsillectomy, Abscess Drainage, Mastitis, Radiotherapy, Malignant Breast Lump Removal, Appendicitis, Anal Fissure, Haematochezia, Hysterectomy, Uterine Dilation and Curettage, Colonoscopy Abnormal
Adverse event resulted in: hospitalization
Suspect drug(s):
Cycrin
Start date: 1999-01-01
Estrace
Dosage: unk, qhs
Start date: 1999-01-01
Estraderm
Start date: 1989-01-01
Estratest
Start date: 1990-01-01
End date: 1999-01-01
Premarin
Dosage: 0.625 unk, unk
Administration route: Oral
Start date: 1989-01-01
Prempro
Indication: Menopause
Start date: 1999-04-01
End date: 2002-04-01
Provera
Dosage: 10 mg, unk
Start date: 1989-01-01
Other drugs received by patient: Steroids NOS; Oxygen Therapy; Lotrel; Cardizem
Adverse event in female receiving Estrace (Estradiol Vaginal)
Reported by a consumer/non-health professional from United States on 2007-06-28
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Estrace
Indication: Hormone Replacement Therapy
Premarin
Prempro
Indication: Hormone Replacement Therapy
Provera
Indication: Hormone Replacement Therapy
|
